Research Beam added a report on “Cardiomyopathy - Pipeline Review, H2 2015” Enquiry about report: http://www.researchbeam.com/cardiomyopathy-pipeline-review-h2-2015-market/enquire-about-report

1. Cardiomyopathy -
Pipeline Review, H2
2015
TELEPHONE: +1 (503) 894-6022
E-MAIL: sales@researchbeam.com

2. Report Overview
Scope
- The report provides a snapshot of the global therapeutic landscape of Cardiomyopathy
- The report reviews key pipeline products under drug profile section which includes, product
description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Cardiomyopathy and
enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Cardiomyopathy products under development by companies and universities/research
institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till
discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Cardiomyopathy pipeline on the basis of target, MoA, route of administration and
molecule type
- Latest news and deals relating related to pipeline products
Read More At : http://www.researchbeam.com/cardiomyopathy-pipeline-review-h2-2015-market

3. Table of Content
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Cardiomyopathy Overview 9
Therapeutics Development 10
Pipeline Products for Cardiomyopathy - Overview 10
Pipeline Products for Cardiomyopathy - Comparative Analysis 11
Cardiomyopathy - Therapeutics under Development by Companies 12
Cardiomyopathy - Therapeutics under Investigation by Universities/Institutes 14
Cardiomyopathy - Pipeline Products Glance 15
Clinical Stage Products 15
Early Stage Products 16
Unknown Stage Products 17
Cardiomyopathy - Products under Development by Companies 18
Cardiomyopathy - Products under Investigation by Universities/Institutes 19
Cardiomyopathy - Companies Involved in Therapeutics Development 20
Array BioPharma Inc. 20
Bioheart, Inc. 21
Gilead Sciences, Inc. 22

4. Report Overview
Reasons to buy
- Provides strategically significant competitor information, analysis, and insights to formulate effective
R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter
strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies - Identify and
understand important and diverse types of therapeutics under development for Cardiomyopathy
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Cardiomyopathy pipeline depth and
focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the
most attractive projects to enhance and expand business potential and Scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that
drove them from pipeline
Enquire At : http://www.researchbeam.com/cardiomyopathy-pipeline-review-h2-2015-
market/enquire-about-report

5. FOR MORE DETAILS
Visit us at :
Stay With Us:
http://www.researchbeam.com/cardiomyopathy-pipeline-review-h2-2015-market
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
TELEPHONE: +1 (800) 910-6452
DIRECT: +1 (503) 894-6022
E-MAIL: sales@researchbeam.com